Literature DB >> 34635919

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

Tim Raine1, Stefanos Bonovas2, Johan Burisch3, Torsten Kucharzik4, Michel Adamina5,6, Vito Annese7, Oliver Bachmann8, Dominik Bettenworth9, Maria Chaparro10, Wladyslawa Czuber-Dochan11, Piotr Eder12, Pierre Ellul13, Catarina Fidalgo14, Gionata Fiorino15, Paolo Gionchetti16, Javier P Gisbert10, Hannah Gordon17, Charlotte Hedin18, Stefan Holubar19, Marietta Iacucci20, Konstantinos Karmiris21, Konstantinos Katsanos22, Uri Kopylov23, Peter L Lakatos24,25, Theodore Lytras26, Ivan Lyutakov27, Nurulamin Noor1, Gianluca Pellino28,29, Daniele Piovani2, Edoardo Savarino30, Francesco Selvaggi28, Bram Verstockt31, Antonino Spinelli2, Yves Panis32, Glen Doherty33.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34635919     DOI： 10.1093/ecco-jcc/jjab178

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  21 in total

1.  Bacillus amyloliquefaciens Enriched Camel Milk Attenuated Colitis Symptoms in Mice Model.

Authors:  Ashraf Khalifa; Abdullah Sheikh; Hairul Islam Mohamed Ibrahim
Journal:  Nutrients       Date:  2022-05-08       Impact factor: 6.706

Review 2.  Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom?

Authors:  Pascal Juillerat; Maude Martinho Grueber; Roseline Ruetsch; Giulia Santi; Marianne Vuillèmoz; Pierre Michetti
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-04-28

Review 3.  Selecting the Best Combined Biological Therapy for Refractory Inflammatory Bowel Disease Patients.

Authors:  Eduard Brunet Mas; Xavier Calvet Calvo
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

Review 4.  An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis.

Authors:  Francesca Ferretti; Rosanna Cannatelli; Maria Camilla Monico; Giovanni Maconi; Sandro Ardizzone
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

5.  Development and validation of a nomogram to predict indolent course in patients with ulcerative colitis: a single-center retrospective study.

Authors:  Na Li; Shukai Zhan; Caiguang Liu; Tong Li; Tong Tu; Baili Chen; Yao He; Minhu Chen; Zhirong Zeng; Xiaojun Zhuang
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-06-30

Review 6.  Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy.

Authors:  Maria Napolitano; Ferdinando D'Amico; Elisa Ragaini; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Drug Des Devel Ther       Date:  2022-06-17       Impact factor: 4.319

7.  Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature.

Authors:  Sara Nikolic; Marco Lanzillotta; Nikola Panic; Torkel B Brismar; Carlos Fernández Moro; Gabriele Capurso; Emanuel Della Torre; J-Matthias Löhr; Miroslav Vujasinovic
Journal:  United European Gastroenterol J       Date:  2022-05-08       Impact factor: 6.866

8.  Daily life difficulties among patients with ulcerative colitis in Japan and the United Kingdom: A comparative study.

Authors:  Aki Kawakami; Makoto Tanaka; Kayoko Sakagami; Lee Meng Choong; Reiko Kunisaki; Shin Maeda; Ingvar Bjarnason; Hiroaki Ito; Bu'Hussain Hayee
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

9.  Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register.

Authors:  Joel Thunberg; Olle Björkqvist; Charlotte R H Hedin; Anders Forss; Charlotte Söderman; Daniel Bergemalm; Ola Olén; Henrik Hjortswang; Hans Strid; Jonas F Ludvigsson; Carl Eriksson; Jonas Halfvarson
Journal:  United European Gastroenterol J       Date:  2022-07-14       Impact factor: 6.866

Review 10.  Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications.

Authors:  Filippo Vernia; Marco Valvano; Salvatore Longo; Nicola Cesaro; Angelo Viscido; Giovanni Latella
Journal:  Nutrients       Date:  2022-01-09       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.